Media

NephroGenex Announces Positive Results For QT Study Of Pyridorin

Orexo commences patent infringement litigation against Actavis

Nexstim stroke treatment covered by US TV channels

Ultragenyx announces positive preliminary data from phase I/II study

Betalutin™ Successful Completion of Phase I Part of Phase I/II Study

Topotarget confirms receipt of acceptance-to-file milestone payment

Top-line data from a Phase 3 clinical trial demonstrates that Zubsolv® is as effective as Suboxone® film in the treatment of opioid dependence

Ultragenyx Announces Results from Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults

Nordic Nanovector´s Betalutin™ granted Orphan-drug Designation